ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1209

Associations Between Rheumatoid Arthritis (RA)-Related Autoimmunity, Joint Symptoms, and Physical Activity in First-Degree Relatives without RA in a Prospective Cohort

Jan M. Hughes-Austin1, Joachim H. Ix2, Samuel R. Ward3, Michael H. Weisman4, James R. O'Dell5, Ted R. Mikuls5, Jane H. Buckner6, Peter K. Gregersen7, Richard M. Keating8, Kevin D. Deane9, V. Michael Holers10 and Jill M. Norris11, 1Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, 2University of California, San Diego, La Jolla, CA, 3Radiology, Orthopaedic Surgery, and Bioengineering, University of California, San Diego, La Jolla, CA, 4Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 5University of Nebraska Medical Center, Omaha, NE, 6Benaroya Research Institute at Virginia Mason, Seattle, WA, 7Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institute for Med Res, Manhasset, NY, 8Division of Rheumatology, Scripps Health, La Jolla, CA, 9Division of Rheumatology, U Colo Denver, Aurora, CO, 10Rheumatology Division, Univ of Colorado School of Med, Aurora, CO, 11University of Colorado Denver, Aurora, CO

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: autoantibodies, Epidemiologic methods, physical activity and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Epidemiology and Public Health Poster II: Pathogenesis and Treatment of Systemic Inflammatory Diseases

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Physical activity in RA patients is significantly less than in counterparts without RA, and many live just above the muscle strength threshold needed for activities of daily living. It is not known whether physical activity declines prior to the onset of RA, potentially because of joint swelling and tenderness or because of the inflammatory processes associated with preclinical autoimmunity. Therefore, we first sought to determine whether RA-related autoantibodies, and joint tenderness and swelling, were associated with physical activity in first-degree relatives (FDRs) of RA patients, a population at increased risk for future RA.

Methods: In the Studies of the Etiology of RA (SERA) (a multicenter prospective study of preclinical RA), we evaluated associations between RA-related autoantibodies (Abs), swollen and tender joint count (SJC, TJC) and hours of physical activity in 233 FDRs. We defined RA-related autoantibody positivity as being positive (+) for any of 5 RA-related Abs: rheumatoid factor (RF), RF isotypes – IgM, IgG, IgA, or anti-cyclic citrullinated peptide (anti-CCP2). Positivity for a High-Risk Profile (HRP) was defined as being (+) for anti-CCP2 and/or 2 or more RF isotypes (IgM, IgG, IgA), which has been shown to be 96% specific for future RA. Hours sleeping, sitting, and engaging in slight, moderate, or heavy activity during a typical 24-hour day were obtained through questionnaire, weighted to reflect metabolic expenditure, and calculated as follows: PA score = (1.0*hsleep + 1.1*hsedentary + 1.5*hslight + 2.4*hmoderate + 5.0*hheavy). ANCOVA was used to evaluate associations between continuous PA score and Ab and HRP positivity, adjusting for age, sex, race, body mass index (BMI), smoking, and TJC. These same methods were used to evaluate associations between SJC and TJC and PA score. Logistic regression was used to evaluate associations between the dichotomous median-and-above (versus < median) PA score and Ab and HRP positivity adjusted for these same covariates.

Results:

Mean age was 47±17 years. 70% were female, 67% were White, 25% were Ab+, and 7% were HRP(+). Mean SJC was 0.3±1 and mean TJC was 1±2 for all FDRs. Average PA score was 37.4. Neither Ab(+) status nor HRP(+) status were associated with PA score or median-and-above PA score in fully adjusted analysis (PA Score: βAb(+)=0.20±1.3, p=88; βHRP(+)=-0.27±0.6, p=0.66) (Median-and-above PA Score Odds Ratios (ORs): ORAb(+)=1.33, 95% CI=0.67-2.67; ORHRP(+)=0.43, 95% CI=0.14-1.30)

Neither SJC nor TJC were significantly associated with PA score in fully adjusted analysis (PA Score: βSJC= -0.54±0.6, p=0.38 βTJC= 0.03±0.3, p=0.91).

Conclusion:

In FDRs of RA patients, neither the number of swollen and tender joints nor autoantibody status was associated with physical activity in cross-sectional analysis.


Disclosure: J. M. Hughes-Austin, None; J. H. Ix, None; S. R. Ward, None; M. H. Weisman, None; J. R. O'Dell, None; T. R. Mikuls, None; J. H. Buckner, None; P. K. Gregersen, None; R. M. Keating, None; K. D. Deane, None; V. M. Holers, Shared patent with Stanford University for use of biomarkers to predict clinical phenotypes in rheumatoid arthritis., 7; J. M. Norris, None.

To cite this abstract in AMA style:

Hughes-Austin JM, Ix JH, Ward SR, Weisman MH, O'Dell JR, Mikuls TR, Buckner JH, Gregersen PK, Keating RM, Deane KD, Holers VM, Norris JM. Associations Between Rheumatoid Arthritis (RA)-Related Autoimmunity, Joint Symptoms, and Physical Activity in First-Degree Relatives without RA in a Prospective Cohort [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/associations-between-rheumatoid-arthritis-ra-related-autoimmunity-joint-symptoms-and-physical-activity-in-first-degree-relatives-without-ra-in-a-prospective-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/associations-between-rheumatoid-arthritis-ra-related-autoimmunity-joint-symptoms-and-physical-activity-in-first-degree-relatives-without-ra-in-a-prospective-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology